Filippo Pietrantonio

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Filippo Pietrantonio
Dec 20, 2024, 13:21 | Insight
Agenus has Announced Five Presentations at 2025 ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers
Presentations will showcase new data reinforcing BOT/BAL’s potential across different lines of treatment in colorectal…
Dec 8, 2024, 13:07 | Insight
Filippo Pietrantonio: Tremelimumab and durvalumab for MSI gastric cancer
Filippo Pietrantonio, GI medical oncologist at the National Cancer Institute of Milan, shared a recent…
Dec 4, 2024, 06:28 | Insight
Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer
Filippo Pietrantonio, GI medical oncologist at the National Cancer Institute of Milan, shared a post…
Nov 28, 2024, 12:51 | Blog
Liver Transplantation for Cholangiocarcinoma After Chemotherapy and SIRT
Arndt Vogel shared on X: "Liver Transplantation for Cholangiocarcinoma After Chemotherapy and SIRT: An Intention-To-Treat Study …
Nov 11, 2024, 03:14 | Insight
Raghav Sundar: Understanding Resistance Mechanisms in HER2+ Gastric Cancer
Raghav Sundar, Leader Gastroesophageal Cancer Program, Associate Professor of Medicine (Oncology), Yale University School of…
Oct 25, 2024, 02:00 | Dialogues
ASCO24 Updates: Dr. Filippo Pietrantonio on ARMANI Trial Findings for Advanced Gastric Cancer
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Oct 23, 2024, 14:20 | Blog
Angelica Petrillo: Recently published key meta-analyses about ICIs in gastric cancer
Angelica Petrillo, Medical Doctor at Ospedale del Mare Napoli, shared a post by Arndt Vogel…
Oct 20, 2024, 13:01 | Insight
Alberto Giovanni Leone: Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma
Alberto Giovanni Leone, HIV/Oncology Fellow at Chelsea and Westminster Hospital NHS Foundation Trust, shared a post…
Sep 15, 2024, 09:40 | Societies
The final analysis of the KEYNOTE-811 trial presented at ESMO24
ESMO shared on LinkedIn: "As presented at ESMO24, the final analysis of the KEYNOTE-811 trial…
Sep 3, 2024, 13:11 | Insight
Julein Taieb: Real world evidence showing 50 MSI-H BRAF V600E mutant treated with immunotherapy
Julein Taieb, Professor, Paris Descartes University, shared a post on LinkedIn: "BRAFmutant, MSI, colorectal cancer…
Aug 7, 2024, 00:27 | Blog
Paolo Tarantino reflects on the results from DESTINY-CRC02 published in the Lancet Oncology
Paolo Tarantino shared on X: “Results from DESTINY-CRC02 published in the Lancet Oncology. Among patients…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 21, 2024, 04:10 | OncoDaily Pulse
OncoDaily Party and Yvonne Award Photos - Part 1
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jul 2, 2024, 04:25 | OncoDaily Pulse
OncoDaily Party and Yvonne Award 2024 Photos - Part 2
On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…
Jun 21, 2024, 02:08 | Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
Apr 18, 2024, 11:57 | Insight
New Paper Alert! The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based on Microsatellite Instability Status
The Differential Impact of Sex on Prognosis and Treatment Efficacy in Resectable Gastric Cancer Based…
All: 16 Posts: 1 - 100
Special Coverage